The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?

This publication has 24 references indexed in Scilit:

• Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
  Free Radical Biology & Medicine, 2001
• Differences in the A?40/A?42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
  Annals of Neurology, 2000
• Cholesterol Modulates the Membrane- Disordering Effects of Beta-Amyloid Peptides in the Hippocampus: Specific Changes in Alzheimer’s Disease
  Dementia and Geriatric Cognitive Disorders, 2000
• Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease
  Journal of Lipid Research, 2000
• Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1999
• Novel Large Apolipoprotein E‐Containing Lipoproteins of Density 1.006–1.060 g/ml in Human Cerebrospinal Fluid
  Journal of Neurochemistry, 1998
• ALZHEIMER'S SOLUBLE AMYLOID BETA PROTEIN IS SECRETED BY HEPG2 CELLS AS AN APOLIPOPROTEIN
  Cell Biology International, 1997
• Biochemical Characterization of Alzheimer's Soluble Amyloid Beta Protein in Human Cerebrospinal Fluid: Association with High Density Lipoproteins
  Biochemical and Biophysical Research Communications, 1996
• The Soluble Form of Alzheimer′s Amyloid β Protein Is Complexed to High Density Lipoprotein 3 and Very High Density Lipoprotein in Normal Human Plasma
  Biochemical and Biophysical Research Communications, 1994
• Cholinergic stimulation of hippocampal pyramidal cells is inhibited by increasing membrane cholesterol
  Brain Research, 1983